Algorithms for Ligand based Virtual Screening in Drug Discovery

被引:0
|
作者
Babaria, Khushboo [1 ]
Das, Shubhankar [1 ]
Ambegaokar, Sanya [1 ]
Palivela, Hemant [1 ]
机构
[1] NMIMS, MPSTME, IT Dept, Bombay, Maharashtra, India
关键词
SVM; Kernel;
D O I
暂无
中图分类号
TP301 [理论、方法];
学科分类号
081202 ;
摘要
Machine learning can play a very important role in various crucial applications like data mining and pattern recognition. Machine learning techniques have been widely used in drug discovery and development, particularly in the areas of chemo-informatics, bioinformatics and other types of pharmaceutical research. It has been demonstrated that they are suitable for large high dimensional data, and the models built with these methods can be used for robust external predictions. This paper discusses on how the machine learning techniques, especially Support Vector Machines, are going to be applied on the data sets with the help of graph kernels. These graph kernels are used to compare substructures of graphs that are computable in polynomial time.
引用
收藏
页码:862 / 866
页数:5
相关论文
共 50 条
  • [21] QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
    Neves, Bruno J.
    Braga, Rodolpho C.
    Melo-Filho, Cleber C.
    Moreira-Filho, Jose Teofilo
    Muratov, Eugene N.
    Andrade, Carolina Horta
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [22] Structure-based virtual screening of chemical libraries for drug discovery
    Ghosh, Sutapa
    Nie, Aihua
    An, Jing
    Huang, Ziwei
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2006, 10 (03) : 194 - 202
  • [23] STRUCTURE-BASED HIGH THROUGHPUT VIRTUAL SCREENING FOR DRUG DISCOVERY
    Jiang, H.
    Shen, J.
    Luo, X.
    Liu, H.
    Chen, F.
    Tan, X.
    Shen, J.
    Chen, K.
    Silman, I.
    Sussman, J. L.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C67 - C67
  • [24] Structure-Based Virtual Screening Accelerates GPCR Drug Discovery
    Liu, Lei
    Jockers, Ralf
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (06) : 382 - 384
  • [25] Structure-based high throughput virtual screening for drug discovery
    Jiang, HL
    Shen, JH
    Luo, XM
    Shen, X
    Liu, H
    Cheng, F
    Shen, JK
    Chen, KX
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 283A - 283A
  • [26] Ligand discovery and virtual screening using the program LIDAEUS
    Taylor, P.
    Blackburn, E.
    Sheng, Y. G.
    Harding, S.
    Hsin, K-Y
    Kan, D.
    Shave, S.
    Walkinshaw, M. D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 : S55 - S67
  • [27] A review of deep learning methods for ligand based drug virtual screening
    Wu, Hongjie
    Liu, Junkai
    Zhang, Runhua
    Lu, Yaoyao
    Cui, Guozeng
    Cui, Zhiming
    Ding, Yijie
    FUNDAMENTAL RESEARCH, 2024, 4 (04): : 715 - 737
  • [28] Integration of virtual screening into the drug discovery process
    Chin, DN
    Chuaqui, CE
    Singh, J
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (10) : 1053 - 1065
  • [29] Virtual screening in drug discovery - A computational perspective
    Reddy, A. Srinivas
    Pati, S. Priyadarshini
    Potukuchi, Praveen Kumar
    Pradeep, H. N.
    Sastry, G. Narahari
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2007, 8 (04) : 329 - 351
  • [30] The holistic integration of virtual screening in drug discovery
    Tanrikulu, Yusuf
    Krueger, Bjoern
    Proschak, Ewgenij
    DRUG DISCOVERY TODAY, 2013, 18 (7-8) : 358 - 364